Latest News
Bolt Biotherapeutics, Inc.
- Bolt Biotherapeutics acquires Prana Therapies, raises $120M
- Wilson Sonsini Advises Prana Therapies on IP Matters Related to Acquisition by Bolt Biotherapeutics
- Bolt Biotherapeutics, Inc. Estimates – LSX:A419U9
- Biotech Stock Bolt Biotherapeutics (Nasdaq: BOLT) Soars on Acquisition News
- Bolt Biotherapeutics, Inc. announced that it expects to receive $119.999995 million in funding from a group of investors
- Bolt Biotherapeutics Acquires Prana Therapies, Secures $120 Million Financing to Advance Clinical Pipeline
- Form 8K Bolt Biotherapeutics For: 23 October By Investing.com
- Bolt Biotherapeutics Completes Prana Merger Alongside $120 Million Financing
- Bolt makes inflammation play with Prana reverse merger, $120M financing
- Bolt Biotherapeutics acquires Prana in reverse merger deal By Investing.com
- BOLT: Prana’s INSPIRE pipeline joins a $120 million-funded push for PRA-216 Phase 2 readouts in 2027
- BOLT Q2 2026 Earnings: Wider-Than-Expected Loss Per Share, Yet Shares Move Higher - Revenue Beat Analysis
Headlines from the last 30 days, linking to the original publishers. See all market news →